Clinical Trials List
2010-12-01 - 2018-12-31
Phase III
Terminated4
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- HSIN-AN HOU Division of Hematology & Oncology
- Shang-Yi Huang Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- 李啟誠 Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Chien-Yuan Chen Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tung-Liang Lin Division of Hematology & Oncology
- Ming-Chung Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jin-Hwang Liu Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- 刁翠美 Division of Pediatrics
- 余垣斌 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- 洪英中 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊陽生 Division of Hematology & Oncology
- Huey-En Tzeng Division of Hematology & Oncology
- 滕傑林 Division of Hematology & Oncology
- Chieh-Lin Teng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
377 participants
